Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
CURRENT ASSETS    
Cash $ 252,549 $ 64,492
Prepaid royalties and licenses 4,575 2,890
Prepaid expenses and other current assets 2,216 446
Total current assets 259,340 67,828
Restricted cash 317,535 266,082
Property, plant and equipment, net 108,388 70,218
TOTAL ASSETS 685,263 404,128
CURRENT LIABILITIES    
Accounts payable 1,481 1,058
Accrued expenses 18,452 26,944
Accrued interest 10,428 4,951
Notes payable – current 265 122
Total current liabilities 30,626 33,075
NON-CURRENT LIABILITIES    
Deferred research and development obligation 1,000 1,000
Deferred revenue 5,000 0
Notes payable 57,224 26,477
Bonds payable 231,809 235,676
Warrant liability 18,258 0
TOTAL LIABILITIES 343,917 296,228
COMMITMENT AND CONTINGENCIES 0 0
STOCKHOLDERS' EQUITY    
Additional paid-in capital 455,475 192,381
Accumulated deficit (114,246) (84,563)
TOTAL STOCKHOLDERS' EQUITY 341,346 107,900
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 685,263 404,128
Common Shares    
STOCKHOLDERS' EQUITY    
Common stock, issued 117 0
Class A Common Units    
STOCKHOLDERS' EQUITY    
Common stock, issued 0 38
Class B Preferred Units    
STOCKHOLDERS' EQUITY    
Preferred stock, issued 0 21
Class B-1 Preferred Units    
STOCKHOLDERS' EQUITY    
Preferred stock, issued 0 16
Class C Profits Units    
STOCKHOLDERS' EQUITY    
Common stock, issued $ 0 $ 7